IFSUF yields 7.96% · PFE yields 6.20%● Live data
📍 IFSUF pulled ahead of the other in Year 1
Combined, IFSUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IFSUF + PFE for your $10,000?
Infrastrutture Wireless Italiane S.p.A. operates in the electronic communications infrastructure sector in Europe. The company offers infrastructure hosting equipment for radio broadcasting, telecommunications, and television, and radio signal broadcasting. It also provides integrated hosting services, including cellular communication and broadcast towers; infrastructures, such as cabling, spaces for equipment, technological plant for power supply, and air-conditioning systems for developing wireless networks, sensors, IoT, and VDS. In addition, the company offers indoor and outdoor mobile networks, such as distributed antenna systems and small cells in public administration, hospitals, airports and stations, museums, production complexes, shopping centers, retail facilities and shops, sports facilities, hotels, amusement parks, credit institutes, offices and co-working spaces, and car parks; and management, development, and backhauling services. It serves network operators; operators with licenses for radio transmission services in other wireless technologies; broadcasting service operators; and institutions, public entities, and the armed forces. The company was incorporated in 2015 and is headquartered in Milano, Italy.
Full IFSUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.